Stryker Acquires Artelon

June 3, 2024

Stryker has signed a definitive agreement to acquire all issued and outstanding shares of Artelon, a privately held developer of soft tissue fixation products for foot & ankle and sports medicine procedures. The deal adds Artelon's synthetic biomaterial technology and product portfolio (with over 60,000 implantations worldwide) to Stryker's foot & ankle and sports medicine offerings and is subject to customary closing conditions.

Buyers
Stryker
Targets
Artelon
Industry
Medical Devices
Location
Georgia, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.